Clinical Trials Browser

INDUSTRY × Various Advanced Cancer × Nivolumab × Clear all

NCT03143153 2026-02-17

CheckMate 648

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

NCT02632409 2025-10-16

CheckMate 274

Phase 3 Active not recruiting

709 enrolled 13 charts 1 FDA

Various Advanced Cancer

NCT02387996 2022-11-01

A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Phase 2 Completed

270 enrolled 14 charts

Various Advanced Cancer

NCT03130959 2022-08-09

CheckMate 908

Phase 2 Completed

166 enrolled 33 charts

Various Advanced Cancer